Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00327860 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Chronic Kidney Disease in Children Prospective Cohort Study (CKiD)

Study acronym: CKiD
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Publications: 203 to 207
    • Eligibility criteria expanded, about 3 words
    v26
  2. Notable Trial status: Active, Not Recruiting to Recruitingv25 Show 7 more changesShow less
    • Enrollment target: 1100 to 1300
    • Eligibility criteria expanded, about 44 words
    • Secondary endpoints: 1 to 2
    • Study description expanded, about 74 words
    • Site details revised at 2 of 2 sites
    • Publications: 195 to 203
    • Study arms: 3 to 4
  3. Minor Publications: 183 to 195v24
  4. Notable Primary and study completion dates: Jul 2023 to Jul 2028
    • Primary endpoint revised
    • Secondary endpoint revised
    v23
  5. Minor Publications: 165 to 183v22
Show 20 earlier versionsHide 20 earlier versions
  1. Minor Publications: 138 to 165v21
  2. Minor Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 1081 to confirmed 1100
    • Site details revised at 2 of 2 sites
    • Publications: 116 to 138
    v20
  3. Minor Re-verified, no change to tracked fieldsv19
  4. Minor Publications: 98 to 116v18
  5. Notable Primary and study completion dates: Jul 2018 to Jul 2023v17 Show 4 more changesShow less
    • Enrollment target: 1196 to 1081
    • Secondary endpoints: details revised at 1 of 1 entry
    • Site contacts updated at 2 of 2 sites
    • Publications: 88 to 98
  6. Notable Trial status: Active, Not Recruiting to Recruitingv16 Show 4 more changesShow less
    • Enrollment target: 891 to 1196
    • Eligibility criteria expanded, about 75 words
    • Study sites revised (2)
    • Publications: 71 to 88
  7. Minor Secondary endpoint revised
    • Eligibility criteria expanded, about 2 words
    v15
  8. Minor Study description expanded, about 50 words
    • Publications: 61 to 71
    v14
  9. Minor Trial status: Recruiting to Active, Not Recruitingv13 Show 5 more changesShow less
    • Enrollment target: estimated 830 to confirmed 891
    • Eligibility criteria revised
    • Site details revised at 2 of 2 sites
    • Collaborators: 4 to 3
    • Publications: 48 to 61
  10. Minor Primary completion date: Jul 2018
    • Study completion date: Jul 2013 to Jul 2018
    • Publications: 26 to 48
    v12
  11. Minor Re-verified, no change to tracked fieldsv11
  12. Notable Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Johns Hopkins Bloomberg School of Public Healthv10 Show 6 more changesShow less
    • Trial status: Active, Not Recruiting to Recruiting
    • Enrollment target: 540 to 830
    • Study completion date: Jul 2008 to Jul 2013
    • Study sites revised (2)
    • Collaborators: 3 to 4
    • Publications: 10 to 26
  13. Minor Eligibility criteria revisedv9
  14. Minor Trial status: Recruiting to Active, Not Recruiting
    • Site details revised at 2 of 2 sites
    v8
  15. Minor Re-verified, no change to tracked fieldsv7
  16. Minor Study completion date: Jul 2008
    • Site contacts updated at 1 of 2 sites
    v6
  17. Minor 4 versions Re-verified since Oct 16, 2006, no change to tracked fieldsv2-v5
  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The Division of Kidney, Urologic, and Hematologic Diseases (DKUHD) of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), in collaboration with the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the National Heart, Lung and Blood Institute (NHLBI) funded a cooperative agreement including two Clinical Coordinating Centers (at Children's Hospital of Philadelphia and at Children's Mercy Hospital in Kansas City), a central biochemistry laboratory (at the University of Minnesota) and a Data Coordinating Center (at Johns Hopkins School of Public Health) to conduct a prospective epidemiological study of children with chronic kidney disease (CKD).
Trial Details
NCT Number NCT00327860
Lead Sponsor Johns Hopkins Bloomberg School of Public Health
Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Heart, Lung, and Blood Institute (NHLBI)
Conditions
(from sponsor)
Chronic Kidney Disease
Related terms Renal Insufficiency, Chronic
Enrollment 1,300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov